NL2030021B1 - L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR - Google Patents

L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR Download PDF

Info

Publication number
NL2030021B1
NL2030021B1 NL2030021A NL2030021A NL2030021B1 NL 2030021 B1 NL2030021 B1 NL 2030021B1 NL 2030021 A NL2030021 A NL 2030021A NL 2030021 A NL2030021 A NL 2030021A NL 2030021 B1 NL2030021 B1 NL 2030021B1
Authority
NL
Netherlands
Prior art keywords
leu
seq
lys
gly
coli
Prior art date
Application number
NL2030021A
Other languages
Dutch (nl)
Inventor
Zhang Susu
Liu Xinli
Wang Ting
Xu Zhenshang
Original Assignee
Univ Qilu Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Qilu Technology filed Critical Univ Qilu Technology
Priority to NL2030021A priority Critical patent/NL2030021B1/en
Application granted granted Critical
Publication of NL2030021B1 publication Critical patent/NL2030021B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/24Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01004L-Arabinose isomerase (5.3.1.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Abstract

The present disclosure provides an L-arabinose isomerase (L-AI) gene derived from Laclococcus lactis (L. lactis), which corresponds to a nucleotide sequence shown in SEQ ID NO. 1 and an amino acid sequence shown in SEQ ID NO. 2. The L-AI gene and a ß- galactosidase (ß-GAL) gene derived from Streptococcus lhermophilus (S. lhermophilus) are inserted into a plasmid pETDuet-l and a resulting recombinant plasmid is transformed into Escherichia coli (E. coli) BL21 (DE3) to enable the simultaneous high- actiVity expression of the two enzymes. The recombinant E. coli strain can directly convert lactose into D-tagatose, which simplifies a production process and reduces a production cost.

Description

L-ARABINOSE ISOMERASE (L-AI) DERIVED FROM LACTOCOCCUS
LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE
SUGAR
TECHNICAL FIELD
[01] The present disclosure belongs to the field of biotechnology, and relates to novel
L-arabinose isomerase (L-Al) and use thereof, and specifically to gene cloning for L-Al of Lactococcus lactis (L. lactis), construction of recombinant Escherichia coli (E. coli) co-expressing L-Al and B-galactosidase (B-GAL), and use of the recombinant strain in the conversion of lactose to produce D-tagatose.
BACKGROUND ART
[02] As the most promising sucrose substitute, D-tagatose can be widely used in various products, including candies and soft drinks. D-tagatose is a recognized safe substance, which can present 92% of the sweetness of sucrose, but only includes 38% of the calories of sucrose. Therefore, D-tagatose is expected to serve as an additive in health foods and functional beverages to improve taste and reduce calories. D-tagatose can also serve as a substitute for sucrose or glucose to treat type 2 diabetes. As D-tagatose has low glycemic index (GI), a patient ingesting D-tagatose undergoes a relatively slow increase in the blood glucose level. In addition, many studies have shown that D-tagatose can be used as a prebiotic to help reduce the cholesterol level, increase the number of probiotics, and prevent colon cancer. Moreover, D-tagatose can also be used to prepare detergents and cosmetics with other optically active compounds and additives. In summary, D-tagatose has huge potential in creating new markets due to its diversified and unique characteristics.
[03] D-tagatose is a natural rare ketohexose present in gums and dairy products at a very low content. At present, the production of D-tagatose can be achieved through a chemical or enzymatic method. However, a chemical production process is very complicated and is accompanied by the generation of by-products, which limits the application of the chemical method. D-tagatose obtained from a biological process is more suitable for consumers, which makes the research on enzymatic production of D- tagatose get attention. With D-galactose as a substrate, D-tagatose can be obtained in vitro through the catalysis of L-Al So far, it has been reported that L-Al can be produced by many microorganisms. The thermophilic L-AI shows the highest activity at a reaction temperature of higher than 70°C. A high temperature promotes the shift of reaction equilibrium toward the formation of D-tagatose, but also exacerbates the undesirable browning reaction and the formation of by-products. In addition, the safety of genes derived from thermophilic bacteria has been questioned.
[04] Enzymatic production of D-tagatose generally uses the expensive D-galactose as a substrate. However, D-galactose can be obtained by hydrolyzing lactose or lactose- containing substances such as whey or whey permeate, which are rich and cheap by- products in the production of dairy products. From a business perspective, the one-step biosynthesis of D-tagatose with lactose as a raw material is very desirable, which requires a recombinant £. coli strain to have highly-active L-AI and B-GAL at the same time.
SUMMARY
[05] In the present disclosure, a novel L-Al gene is obtained from Z. lactis, and the gene 1s allowed to co-express with a B-GAL gene from Streptococcus thermophilus (S. thermophilus) in E. coli. The recombinant strain can directly convert lactose into D- tagatose.
[06] The present disclosure adopts the following technical solutions:
[07] A first objective of the present disclosure is to provide novel L-Al with an amino acid sequence shown in SEQ ID No. 2.
[08] A second objective of the present disclosure is to provide a gene encoding the aforementioned novel L-Al, with a nucleotide sequence shown in SEQ ID No. 1.
[09] Further, the nucleotide sequence shown in SEQ ID No. | may be present in Z. lactis.
[10] A third objective of the present disclosure is to provide a recombinant £. coli strain. The recombinant E. coli strain is constructed as follows: A specific primer pair is used to amplify the L-AI gene described above. The primer pair includes the following two sequences:
[11] upstream primer Fl (5'-GCGCATATGTTAGAAAATACTCAAAAAG-3) (SEQ ID No. 3) and
[12] downstream primer R1 (5'-GCGCTCGAGTCATCCAAGATTAATATAAG-3") (SEQ ID No. 4).
[13] Specifically, the specific primer pair shown in SEQ ID No. 3 and SEQ ID No. 4 is used to amplify the L-AI gene shown in SEQ ID No. 1; and a PCR amplification product is subjected to double enzyme digestion with Nde 1 and Xho 1, an expression vector pETDuet-1 is linearized through the same enzyme digestion, and digestion products of the amplification product are ligated with the linearized expression vector to construct a recombinant expression vector pETDuet-ara.
[14] Further, a specific primer pair is used to amplify a B-GAL gene of S. thermophilus. The primer pair includes the following two sequences:
[15] F2 (5'-CGCGGATCCGATGAACATGACTGAAAAAATTC-3') (SEQ ID No. 5)and
[16] R2 (5'-GCGCTGCAGCTAATTTAGTGGTTCAATCATGAAG-3") (SEQ ID
No. 6).
[17] Specifically, the specific primer pair shown in SEQ ID No. 5 and SEQ ID No. 6 is used to amplify the B-GAL gene of S. thermophilus; and a PCR amplification product is subjected to double enzyme digestion with Bam HI and Pst L the recombinant expression vector pETDuet-ara is linearized through the same enzyme digestion, and products of the amplification product are ligated with the linearized recombinant expression vector to construct a recombinant expression vector pETDuet-ara-gal. The recombinant expression vector pETDuet-ara-gal is transformed into a host strain £. coli
BL21 (DE3), a transformant is cultivated, and protein expression is induced by isopropyl-B-D-thiogalactoside (IPTG) or lactose.
[18] A fourth objective of the present disclosure is to provide use of the aforementioned recombinant £. coli strain in the conversion of lactose into D-tagatose.
[19] The present disclosure has the following beneficial effects:
[20] 1. The L-AI gene provided by the present disclosure is produced by ZL. lactis, and the L. lactis is a recognized safe strain, which has been used in the food industry for a long time and shows high biological safety.
[21] 2. The recombinant £. coli strain provided by the present disclosure can directly use cheap lactose as a substrate to produce D-tagatose through one-step conversion, which greatly reduces a production cost.
[22] 3. 50°C is the optimal temperature for the conversion of the recombinant strain of the present disclosure to produce D-tagatose, which is a suitable temperature. A too- low temperature will reduce the conversion speed and conversion efficiency, and a too-
high temperature will cause the formation of by-products.
BRIEF DESCRIPTION OF THE DRAWINGS
[23] FIG. 1 shows the expression of L-Al and B-GAL in recombinant £. coli (the bands indicated by arrows represent L-Al and B-GAL, respectively; W represents whole cell components; and S represents soluble protein components).
[24] FIG. 2 shows the optimization of conditions for the conversion of galactose into
D-tagatose by recombinant E. coli (A: the activity change of recombinant E. coli under the induction conditions of 16°C (2), 20°C (0), 25°C (A), 30°C (V), and 37°C (<3); B: conversion rates of bacteria in different volumes of fermentation broth; and C: the optimal temperature for long-term reaction).
[25] FIG. 3 shows the conversion of galactose into D-tagatose by recombinant £. coli (A: lactose conversion rates (m) and D-tagatose yields (white bar) of recombinant £. coli at different lactose concentrations; and B: changes of D-galactose concentration (m) and
D-tagatose concentration (®) and yield (white bar) in a 300 g/L lactose solution with recombinant £. coli over time).
DETAILED DESCRIPTION OF THE EMBODIMENTS
[26] To make the to-be-solved technical problems, technical solutions, and advantages of the present disclosure clearer, the present disclosure will be described in detail below with reference to the accompanying drawings and specific examples.
However, the present disclosure is definitely not limited to these examples. The following examples are merely preferred examples of the present disclosure, which are only used to explain the present disclosure, and should not be understood as a limitation to the patent scope of the present disclosure. It should be noted that any modifications, equivalent substitutions, and improvements made within the spirit and principle of the present disclosure should be included within the protection scope of the present disclosure. Therefore, the protection scope of the present disclosure should be subject to the appended claims.
[27] Unless otherwise specified, the components used in the present disclosure are all commercially available products.
[28] I. lactis used is a common commercial product.
[29] S. thermophilus used is a common commercial product.
[30] Example 1: Cloning of an L-Al gene from ZL. /actis and a B-GAL gene from SS. thermophilus
[31] LL. lactis and S. thermophilus strains were each activated overnight and then centrifuged to collect bacteria. Lysozyme and protease K were added the bacteria at an 5 appropriate amount to lyse cells and remove proteins, then 20% SDS was added, and a resulting mixture was incubated in a water bath at 65°C for 2 h. 3 mL of pre-cooled chloroform was added, and a resulting mixture was thoroughly mixed and centrifuged to obtain a supernatant. An equal volume of a pre-cooled mixed solution of phenol, chloroform, and isoamyl alcohol (25:24:1) was added to the supernatant, and a resulting mixture was thoroughly mixed by inverting up and down and then centrifuged; an equal volume of a mixture of chloroform and isoamyl alcohol (24:1) was added to a resulting upper aqueous phase, and a resulting mixture was centrifuged once again; and 0.6-fold volume of pre-cooled isopropyl alcohol (IPA) was added to a resulting aqueous phase, a resulting mixture was incubated in a water bath at room temperature to conduct alcohol precipitation for 1 h, and a resulting precipitate was collected by centrifugation. Finally, the precipitate was washed twice with 70% ethanol and then blow-dried, and DNA was dissolved in TE buffer.
[32] The L-AI gene from JL. lactis was amplified using the following primers: upstream primer F1 (S'-GCGCATATGTTAGAAAATACTCAAAAAG-3') (SEQ
ID No. 3) and downstream primer R1 (5'-
GCGCTCGAGTCATCCAAGATTAATATAAG-3") (SEQ ID No. 4). PCR reaction system (50 pL): ultrapure water (UPW): 20 ul; 2 x Taq Master Mix: 25 uL; upstream and downstream primers (10 uM): each 2 uL; and DNA template: 1 uL. PCR reaction conditions: 95°C for 5 min; 95°C for 30 s, 50°C for 30 s, and 72°C for 90 s, 30 cycles; and 72°C for 10 min. A PCR product was subjected to electrophoresis and gel extraction to obtain a purified L-AI gene PCR product.
[33] The B-GAL gene from S. thermophilus was amplified using the following primers: upstream primer F2 (5'-CGCGGATCCGATGAACATGACTGAAAAAATTC- 3) (SEQ ID No. 5) and downstream primer R2 (5'-
GCGCTGCAGCTAATTTAGTGGTTCAATCATGAAG-3') (SEQ ID No. 6). PCR reaction system (50 uL): UPW: 20 ul; 2 x Taq Master Mix: 25 pL; upstream and downstream primers (10 uM): each 2 pL; and DNA template: 1 uL. PCR reaction conditions: 95°C for 5 min; 95°C for 30 s, 50°C for 30 s, and 72°C for 3 min and 15 5,
30 cycles; and 72°C for 10 min. A PCR product was subjected to electrophoresis and gel extraction to obtain a purified B-GAL gene PCR product.
[34] Example 2: L-Al gene and B-GAL gene linking vector and protein expression
[35] The L-Al gene PCR product was subjected to double enzyme digestion with Nde land XhoI for 3 h. Digestion system (100 uL): Nae 1: 5 pL; Xho I. 5 pL; 10 x K Buffer: uL; 0.1% BSA: 10 uL; DNA: 5 pg; and sterile water. Gel extraction was conducted to obtain purified digestion fragments. A pETDuet-1 plasmid was subjected to double enzyme digestion for 3 h. Digestion system (100 pL): Nae I: 5 pL; Xho I. 5 uL; 10 x K
Buffer: 10 pL; 0.1% BSA: 10 uL; DNA: 5 ug; and sterile water. Gel extraction was 10 conducted to obtain a purified digestion plasmid. The DNA fragments and the pETDuet- 1 vector obtained after the double enzyme digestion were mixed at a molar ratio of 10:1, then T4 DNA ligase was added, and a resulting mixture was subjected to ligation overnight at 16°C. 10 pL of a ligation product was added to 100 pL of £. coli BL21(DE3) competent cells, and a resulting mixture was incubated on ice for 30 min and then subjected to heat shock for 60 s in a 42°C water bath; and then 900 pL of a LB liquid medium was added, and a resulting mixture was incubated for 1 h (37°C and 150 rpm).
A resulting bacterial solution was centrifuged, and 800 uL of a resulting supernatant was removed; and the bacteria were resuspended in the remaining medium, and a resulting bacterial suspension was spread on an LB plate with 100 pg/mL ampicillin. A transformant was sequenced, and a sequencing result was consistent with the nucleotide sequence of the L-Al gene (as shown in SEQ ID NO. 1). The plasmid pETDuet-1 integrated with the L-AI gene was named pETDuet-ara.
[36] The B-GAL gene PCR product was subjected to double enzyme digestion with
Bam HI and Pst 1 for 3 h. Digestion system (100 pL): Bam HI: 5 uL; Pst 1: 5 uL; 10 x K
Buffer: 10 pL; 0.1% BSA: 10 uL; DNA: 5 ug; and sterile water. Gel extraction was conducted to obtain purified digestion fragments. The plasmid pETDuet-ara was subjected to double enzyme digestion for 3 h. Digestion system (100 uL): Bam HT: 5 ul,
PstT: 5 uL; 10 = K Buffer: 10 pL; 0.1% BSA: 10 uL; DNA: 5 ug; and sterile water. Gel extraction was conducted to obtain a purified digestion plasmid. The DNA fragments and the pETDuet-ara vector obtained after the double enzyme digestion were mixed at a molar ratio of 10:1, then T: DNA ligase was added, and a resulting mixture was subjected to ligation overnight at 16°C. 10 uL of a ligation product was added to 100 uL of £. coli BL21 (DE3) competent cells, and a resulting mixture was incubated on ice for
30 min and then subjected to heat shock for 60 s in a 42°C water bath; and then 900 pL of a LB liquid medium was added, and a resulting mixture was incubated for 1 h (37°C and 150 rpm). A resulting bacterial solution was centrifuged, and 800 uL of a resulting supernatant was removed; and the bacteria were resuspended in the remaining medium, and a resulting bacterial suspension was spread on an LB plate with 100 pg/mL ampicillin. A transformant was sequenced, and a sequencing result was consistent with the nucleotide sequence of the B-GAL gene. The plasmid pETDuet-ara integrated with the B-GAL gene was named pETDuet-ara-gal.
[37] A recombinant expression strain was inoculated into an LB liquid medium and cultivated overnight at 37°C. A resulting bacterial solution was inoculated into 100 mL of an LB liquid medium at an inoculation volume of 1%, and cultivated at 37°C; and after the bacteria grew to an OD of 0.6, IPTG or 2% lactose was added at a final concentration of 0.5 mM to induce protein expression. Polyacrylamide gel electrophoresis (PAGE) was used to detect the protein expression. As shown in FIG. 1, both L-AI and B-GAL underwent soluble expression in large amounts.
[38] Example 3: Determination of the optimal conversion conditions for recombinant £. coli
[39] In atemperature range of 30°C to 60°C, the optimal temperature for conversion of lactose into D-tagatose by recombinant £. coli was studied. In a pH range of 4.0 to 9.0, the optimal pH for conversion of lactose into D-tagatose by recombinant £. coli was studied. Results showed that the optimal temperature was 50°C and the optimal pH was 8.0.
[40] The effects of induction temperature, cell dosage, and long-term reaction temperature on the reaction were further studied. The £. coli was inoculated into a fermentation broth and subjected to induction cultivation at 16°C, 20°C, 25°C, 30°C, and 37°C, separately. As shown in FIG. 2A, the maximum activity was detected after 24 h of incubation at 20°C. Cells were collected at regular intervals to determine the conversion efficiency. Bacteria were collected from 0.5 ml, 1 ml, 3 ml, 5 ml, 7 ml, 9 ml, 11 ml, and 13 mL of fermentation broth, separately, and the effects of cell dosages on the production of D-tagatose were compared. Results showed that the optimal dosage was 9 mL of fermentation broth (FIG. 2 B). A reaction mixture was incubated at 30°C to 60°C for 24 h to determine the optimal long-term reaction temperature. As shown in
FIG. 2C, the maximum yield of D-tagatose was detected at 50°C.
[41] Example 4: Conversion of lactose into D-tagatose by the recombinant strain
[42] Lactose solutions with different concentrations were used as substrates to compare the conversion efficiencies of the recombinant strain to produce D-tagatose.
Bacterial cells (about 1.7 g of wet cells) in 90 mL of fermentation broth were collected, and added to 100 mM phosphate buffers (pH 8.0) with final lactose concentrations of 50 g/L, 100 g/L, 150 g/L, 200 g/L, 250 g/L, and 300 g/L, and bioconversion was conducted at 50°C. The bioconversion was conducted for 24 h, during which samples were collected every 4 h to quantitatively analyze the concentrations of lactose, D-galactose, and D-tagatose through HPLC.
[43] Results showed that, with the increase of the substrate lactose concentration, the
D-tagatose yield continued to increase, with a maximum value of 2.65 g/L/h. The conversion rate of D-galactose increased first and then remained unchanged, and the conversion rate was 42.4% at a lactose concentration of 300 g/L. (FIG. 3A). The production of D-tagatose at a lactose concentration of 300 g/L was tracked. At the initial 3 h, the substrate lactose was completely hydrolyzed, and the conversion rate reached 20.5%. The maximum conversion rate of 42.4% was achieved at 15 h (FIG. 3B).
Sequence Listing <110> Xu Zhenshang
Wang Ting
Liu Xinli
Zhang Susu <120> L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS
LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR <160> 6 <170> SIPOSequenceListing 1.0 <210> 1 <211> 1425 <212> DNA <213> L. lactis <400> 1 atgttagaaa atactcaaaa agaattttgg tttgttacag ggtctcaatt tttatatggt 60 ccagaagctt tggcgactgt tgaaaaaaat gctcgaaaag tagttgacga aatgaataat 120 tctggtagcc tcccttatcc aattattttt aaaatagttg caacaactgc tgaaaatatt 180 actcaaatta tgaaggaagc aaattatcag gatgaagttg cgggcgtgat tacatggatg 240 cacacctttt ctccagccaa aaactggatt cgtgggacac aacttttaaa taaaccctta 300 ctacacttag ctactcaatt tttgaaccat attccttaca aaacgattga ttttgattat 360 atgaatgtaa atcaatcagc tcatggtgac cgagaatatg cttttatcaa tgcacgtttg 420 aaaaaaaata ataagattat atttggccat tgggaagatg atgaaattag acaacaaatc 480 gctaaatgga tgaatgttge ggtggcttac aatgaatcct ataaaataaa aatcgttaca 540 tttgctgata aaatgcgaga tgtcgctgtt acggacggag ataaagttga agcgcaaatt 600 aaatttggct ggacggttga ttattgggga gtaggtgatt tagtagaata tgttaatget 660 gtagcagaga gtgatattaa tcagctttat aaagatttac aaagtaaata tgattatatt 720 gaaggaaaca atagtccgga aaaattcgaa aaaaatgtta aatatcaatt acgtgaatat 780 ttaggaatta agaaatttat ggacgataaa ggctatagtg cctttactac taactttgaa 840 gacttgatag gcttagaaca attacctgga cttgcagcac aattactttt ggctgatggt 900 tatggattcg ctggagaagg agattggaaa acagcagcac ttgtccgtct gttcaaaatt 960 atggcgcata ataaagaaac agtctttatg gaagattata ctttggattt gcgtcaagga 1020 cacgaagcaa ttcttgggtc acacatgctt gaagttgatc cttcaatagc atcagacaag 1080 ccacgagttg aggttcatcc gttagatatt ggtggtaagt cagatccagc acgettagta 1140 ttcacaggta tgattggtga agctgttgat attactatgg cagattatgg aaatgaattt 1200 aagttaattt cttatgaggt tactggaaat aaaccagaag aagaaactcc gttcttacca 1260 gttgctaagc agctctggac gcctaaacaa ggattaaaag ttggggctga acaatggtta 1320
IO aaagcaggag ggggacatca tactgtttta tcttttgtgg ttgattcaga acaaattggt 1380 gatttgtgtg caatgtttgg actaacttat attaatcttg gatga 1425 <210> 2 <211> 474 <212> PRT <213> L. lactis <400> 2
Met Leu Glu Asn Thr Gln Lys Glu Phe Trp Phe Val Thr Gly Ser Gln 1 5 10 15
Phe Leu Tyr Gly Pro Glu Ala Leu Ala Thr Val Glu Lys Asn Ala Arg 20 25 30
Lys Val Val Asp Glu Met Asn Asn Ser Gly Ser Leu Pro Tyr Pro Ile 35 40 45
Ile Phe Lys Ile Val Ala Thr Thr Ala Glu Asn Ile Thr Gln Ile Met 50 55 60
Lys Glu Ala Asn Tyr Gln Asp Glu Val Ala Gly Val Ile Thr Trp Met 65 70 75 80
His Thr Phe Ser Pro Ala Lys Asn Trp Ile Arg Gly Thr Gln Leu Leu 85 90 95
Asn Lys Pro Leu Leu His Leu Ala Thr Gln Phe Leu Asn His Ile Pro 100 105 110
Tyr Lys Thr Ile Asp Phe Asp Tyr Met Asn Val Asn Gln Ser Ala His
115 120 125
Gly Asp Arg Glu Tyr Ala Phe Ile Asn Ala Arg Leu Lys Lys Asn Asn 130 135 140
Lys Ile Ile Phe Gly His Trp Glu Asp Asp Glu Ile Arg Gln Gln Ile 145 150 155 160
Ala Lys Trp Met Asn Val Ala Val Ala Tyr Asn Glu Ser Tyr Lys Ile 165 170 175
Lys Ile Val Thr Phe Ala Asp Lys Met Arg Asp Val Ala Val Thr Asp 180 185 190
Gly Asp Lys Val Glu Ala Gln Ile Lys Phe Gly Trp Thr Val Asp Tyr 195 200 205
Trp Gly Val Gly Asp Leu Val Glu Tyr Val Asn Ala Val Ala Glu Ser 210 215 220
Asp Ile Asn Gln Leu Tyr Lys Asp Leu Gln Ser Lys Tyr Asp Tyr lle 225 230 235 240
Glu Gly Asn Asn Ser Pro Glu Lys Phe Glu Lys Asn Val Lys Tyr Gln 245 250 255
Leu Arg Glu Tyr Leu Gly Ile Lys Lys Phe Met Asp Asp Lys Gly Tyr 260 265 270
Ser Ala Phe Thr Thr Asn Phe Glu Asp Leu Ile Gly Leu Glu Gln Leu 275 280 285
Pro Gly Leu Ala Ala Gln Leu Leu Leu Ala Asp Gly Tyr Gly Phe Ala 290 295 300
Gly Glu Gly Asp Trp Lys Thr Ala Ala Leu Val Arg Leu Phe Lys Ile 305 310 315 320
Met Ala His Asn Lys Glu Thr Val Phe Met Glu Asp Tyr Thr Leu Asp 325 330 335
Leu Arg Gln Gly His Glu Ala Ile Leu Gly Ser His Met Leu Glu Val 340 345 350
Asp Pro Ser Ile Ala Ser Asp Lys Pro Arg Val Glu Val His Pro Leu 355 360 365
Asp Ile Gly Gly Lys Ser Asp Pro Ala Arg Leu Val Phe Thr Gly Met 370 375 380
Ile Gly Glu Ala Val Asp Ile Thr Met Ala Asp Tyr Gly Asn Glu Phe 385 390 395 400
Lys Leu Ile Ser Tyr Glu Val Thr Gly Asn Lys Pro Glu Glu Glu Thr 405 410 415
Pro Phe Leu Pro Val Ala Lys Gln Leu Trp Thr Pro Lys Gln Gly Leu 420 425 430
Lys Val Gly Ala Glu Gln Trp Leu Lys Ala Gly Gly Gly His His Thr 435 440 445
Val Leu Ser Phe Val Val Asp Ser Glu Gln Ile Gly Asp Leu Cys Ala 450 455 460
Met Phe Gly Leu Thr Tyr Ile Asn Leu Gly 465 470 <210> 3 <211> 28 <212> DNA <213> L. lactis <400> 3 gcgcatatgt tagaaaatac tcaaaaag 28 <210> 4 <211> 29 <212> DNA <213> L. lactis <400> 4 gcgctcgagt catccaagat taatataag 29 <210> 5 <211> 32 <212> DNA <213> L. lactis
<400> 5 cgcggatccg atgaacatga ctgaaaaaat tc 32 <210> 6 <211> 34 <212> DNA <213> L. lactis <400> 6 gcgctgcagc taatttagtg gttcaatcat gaag 34
SEQLTXT
SEQUENCE LISTING
<110> Zhenshang, Xu
Ting, Wang
Xinli, Liu
Susu, Zhang <120> L-ARABINOSE ISOMERASE (L-AI) DERIVED FROM LACTOCOCCUS LACTIS (L.
LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR <130> HKJP202110327 <160> 6 <170> PatentIn version 3.5 <210> 1 <211> 1425 <212> DNA <213> Lactococcus lactis <400> 1 atgttagaaa atactcaaaa agaattttgg tttgttacag ggtctcaatt tttatatggt 60 ccagaagctt tggcgactgt tgaaaaaaat gctcgaaaag tagttgacga aatgaataat 120 tctggtagcc tcccttatcc aattattttt aaaatagttg caacaactgc tgaaaatatt 180 actcaaatta tgaaggaagc aaattatcag gatgaagttg cgggcgtgat tacatggatg 240 cacacctttt ctccagccaa aaactggatt cgtgggacac aacttttaaa taaaccctta 300 ctacacttag ctactcaatt tttgaaccat attccttaca aaacgattga ttttgattat 360 atgaatgtaa atcaatcagc tcatggtgac cgagaatatg cttttatcaa tgcacgtttg 420 aaaaaaaata ataagattat atttggccat tgggaagatg atgaaattag acaacaaatc 480 gctaaatgga tgaatgttgc ggtggcttac aatgaatcct ataaaataaa aatcgttaca 540 tttgctgata aaatgcgaga tgtcgctgtt acggacggag ataaagttga agcgcaaatt 600 aaatttggct ggacggttga ttattgggga gtaggtgatt tagtagaata tgttaatgct 660 gtagcagaga gtgatattaa tcagctttat aaagatttac aaagtaaata tgattatatt 720 gaaggaaaca atagtccgga aaaattcgaa aaaaatgtta aatatcaatt acgtgaatat 780 ttaggaatta agaaatttat ggacgataaa ggctatagtg cctttactac taactttgaa 840 gacttgatag gcttagaaca attacctgga cttgcagcac aattactttt ggctgatggt 900
Pagina 1
SEQLTXT tatggattcg ctggagaagg agattggaaa acagcagcac ttgtccgtct gttcaaaatt 960 atggcgcata ataaagaaac agtctttatg gaagattata ctttggattt gcgtcaagga 1020 cacgaagcaa ttcttgggtc acacatgctt gaagttgatc cttcaatagc atcagacaag 1080 ccacgagttg aggttcatcc gttagatatt ggtggtaagt cagatccagc acgcttagta 1140 ttcacaggta tgattggtga agctgttgat attactatgg cagattatgg aaatgaattt 1200 aagttaattt cttatgaggt tactggaaat aaaccagaag aagaaactcc gttcttacca 1260 gttgctaagc agctctggac gcctaaacaa ggattaaaag ttggggctga acaatggtta 1320 aaagcaggag ggggacatca tactgtttta tcttttgtgg ttgattcaga acaaattggt 1380 gatttgtgtg caatgtttgg actaacttat attaatcttg gatga 1425 <210> 2 <211> 474 <212> PRT <213> Lactococcus lactis <400> 2
Met Leu Glu Asn Thr Gln Lys Glu Phe Trp Phe Val Thr Gly Ser Gln 1 5 10 15
Phe Leu Tyr Gly Pro Glu Ala Leu Ala Thr Val Glu Lys Asn Ala Arg
Lys Val Val Asp Glu Met Asn Asn Ser Gly Ser Leu Pro Tyr Pro Ile
Ile Phe Lys Ile Val Ala Thr Thr Ala Glu Asn Ile Thr Gln Ile Met 60
Lys Glu Ala Asn Tyr Gln Asp Glu Val Ala Gly Val Ile Thr Trp Met 65 70 75 80
His Thr Phe Ser Pro Ala Lys Asn Trp Ile Arg Gly Thr Gln Leu Leu 85 90 95
Asn Lys Pro Leu Leu His Leu Ala Thr Gln Phe Leu Asn His Ile Pro 100 105 110
Pagina 2
SEQLTXT
Tyr Lys Thr Ile Asp Phe Asp Tyr Met Asn Val Asn Gln Ser Ala His 115 120 125
Gly Asp Arg Glu Tyr Ala Phe Ile Asn Ala Arg Leu Lys Lys Asn Asn 130 135 140
Lys Ile Ile Phe Gly His Trp Glu Asp Asp Glu Ile Arg Gln Gln Ile 145 150 155 160
Ala Lys Trp Met Asn Val Ala Val Ala Tyr Asn Glu Ser Tyr Lys Ile 165 170 175
Lys Ile Val Thr Phe Ala Asp Lys Met Arg Asp Val Ala Val Thr Asp 180 185 190
Gly Asp Lys Val Glu Ala Gln Ile Lys Phe Gly Trp Thr Val Asp Tyr 195 200 205
Trp Gly Val Gly Asp Leu Val Glu Tyr Val Asn Ala Val Ala Glu Ser 210 215 220
Asp Ile Asn Gln Leu Tyr Lys Asp Leu Gln Ser Lys Tyr Asp Tyr Ile 225 230 235 240
Glu Gly Asn Asn Ser Pro Glu Lys Phe Glu Lys Asn Val Lys Tyr Gln 245 250 255
Leu Arg Glu Tyr Leu Gly Ile Lys Lys Phe Met Asp Asp Lys Gly Tyr 260 265 270
Ser Ala Phe Thr Thr Asn Phe Glu Asp Leu Ile Gly Leu Glu Gln Leu 275 280 285
Pro Gly Leu Ala Ala Gln Leu Leu Leu Ala Asp Gly Tyr Gly Phe Ala 290 295 300
Gly Glu Gly Asp Trp Lys Thr Ala Ala Leu Val Arg Leu Phe Lys Ile 305 310 315 320
Pagina 3
SEQLTXT
Met Ala His Asn Lys Glu Thr Val Phe Met Glu Asp Tyr Thr Leu Asp 325 330 335
Leu Arg Gln Gly His Glu Ala Ile Leu Gly Ser His Met Leu Glu Val 340 345 350
Asp Pro Ser Ile Ala Ser Asp Lys Pro Arg Val Glu Val His Pro Leu 355 360 365
Asp Ile Gly Gly Lys Ser Asp Pro Ala Arg Leu Val Phe Thr Gly Met 370 375 380
Ile Gly Glu Ala Val Asp Ile Thr Met Ala Asp Tyr Gly Asn Glu Phe 385 390 395 400
Lys Leu Ile Ser Tyr Glu Val Thr Gly Asn Lys Pro Glu Glu Glu Thr 405 410 415
Pro Phe Leu Pro Val Ala Lys Gln Leu Trp Thr Pro Lys Gln Gly Leu 420 425 430
Lys Val Gly Ala Glu Gln Trp Leu Lys Ala Gly Gly Gly His His Thr 435 440 445
Val Leu Ser Phe Val Val Asp Ser Glu Gln Ile Gly Asp Leu Cys Ala 450 455 460
Met Phe Gly Leu Thr Tyr Ile Asn Leu Gly 465 470 <2105 3 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> upstream primer F1 for amplifying the L-AI gene <400> 3 gcgcatatgt tagaaaatac tcaaaaag 28
Pagina 4
SEQLTXT
<2105 4 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> downstream primer R1 for amplifying the L-AI gene <400> 4 gcgctcgagt catccaagat taatataag 29 <210>5 5 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> primer F2 for amplifying a |A-GAL gene of S. thermophilus <400> 5 cgcggatccg atgaacatga ctgaaaaaat tc 32 <210> 6 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> primer R2 for amplifying a |A-GAL gene of S. thermophilus <400> 6 gcgctgcagc taatttagtg gttcaatcat gaag 34
Pagina 5

Claims (6)

Conclusies l. Nieuw gen dat codeert voor L-arabinose-isomerase (L-Al), waarbij het nieuwe gen dat codeert voor L-AI een nucleotidesequentie heeft die getoond is in SEQ ID No. 1.Conclusions l. Novel gene encoding L-arabinose isomerase (L-Al), wherein the novel gene encoding L-AI has a nucleotide sequence shown in SEQ ID NO. 1. 2. Nieuw L-arabinose-isomerase (L-AD), waarbij het nieuwe L-AI een aminozuursequentie heeft die getoond is in SEQ ID No. 2.2. Novel L-arabinose isomerase (L-AD), wherein the novel L-AI has an amino acid sequence shown in SEQ ID NO. 2. 3. Nieuw gen dat codeert voor L-arabinose-isomerase (L-Al) volgens conclusie 1, waarbij de sequentie aanwezig is in Lactococcus lactis (L. lactis).The novel gene encoding L-arabinose isomerase (L-A1) according to claim 1, wherein the sequence is present in Lactococcus lactis (L. lactis). 4. Bereidingswerkwijze voor een recombinante stam van Escherichia coli (E. coli), waarbij de werkwijze het volgende omvat: het gebruiken van specifieke primers Fl (5’-GCGCATATGTTAGAAAATACTCAAAAAG-3’) (SEQ ID No. 3) en RI (5-GCGCTCGAGTCATCCAAGATTAATATAAG-3") (SEQ ID No. 4) om het nieuwe gen dat codeert voor L-arabinose-isomerase (L-AT) volgens conclusie 1 te amplificeren; het onderwerpen van PCR-amplificatieproduct aan dubbele enzymdigestie met Neel en Xhol, het lineair maken van een expressievector pETDuet-1 door dezelfde enzymdigestie, en het ligeren van digestieproducten van het amplificatieproduct met de lineair gemaakte expressievector om een recombinante expressievector pETDuet-ara te construeren; het gebruiken van specifieke primers F2 (5-CGCGGATCCGATGAACATGACTGAAAAAATTC-3") (SEQ ID No. 5) en R2 (5’-GCGCTGCAGCTAATTTAGTGGTTCAATCATGAAG-3’) (SEQ ID No. 6) om een B-galactosidase- (B-GAL-) gen van Streptococcus thermophilus (S. thermophilus) te amplificeren; het onderwerpen van een PCR-amplificatieproduct aan dubbele digestie met Bam HI en PST, het lineair maken van de recombinante expressievector pETDuet- ara door dezelfde enzymdigestie, en het ligeren van digestieproducten van het amplificatieproduct met de lineair gemaakte recombinante expressievector om een recombinante expressievector pETDuet-ara-gal te construeren, en het transformeren van de recombinante expressievector pETDuet-ara-gal in een gastheerstam E. coli BL21A method of preparation for a recombinant strain of Escherichia coli (E. coli), the method comprising: using specific primers F1 (5'-GCGCATATGTTAGAAAATACTCAAAAAG-3') (SEQ ID No. 3) and RI (5- GCGCTCGAGTCATCCAAGATTAATATAAG-3") (SEQ ID No. 4) to amplify the novel gene encoding L-arabinose isomerase (L-AT) according to claim 1; subjecting PCR amplification product to double enzyme digestion with Neel and Xhol, linearizing an expression vector pETDuet-1 by the same enzyme digestion, and ligating digestion products of the amplification product with the linearized expression vector to construct a recombinant expression vector pETDuet-ara; using specific primers F2 (5-CGCGGATCCGATGAACATGACTGAAAAAATTC-3") ( SEQ ID No. 5) and R2 (5'-GCCGCTGCAGCTAATTTAGTGGTTCAATCATGAAG-3') (SEQ ID No. 6) to amplify a β-galactosidase (β-GAL) gene from Streptococcus thermophilus (S. thermophilus); subjecting a PCR amplification product to double digestion with Bam HI and PST, linearizing the recombinant expression vector pETDuet-ara by the same enzyme digestion, and ligating digestion products of the amplification product with the linearized recombinant expression vector to form a recombinant expression vector pETDuet- ara-gal, and transforming the recombinant expression vector pETDuet-ara-gal into a host strain E. coli BL21 (DE3), het kweken van een transformant, en het induceren van eiwitexpressie middels isopropyl- B-D-thiogalactoside (IPTG) of lactose.(DE3), culturing a transformant, and inducing protein expression by isopropyl-β-D-thiogalactoside (IPTG) or lactose. 5. Bereidingswerkwijze van een recombinante stam van Escherichia coli (E. coli) volgens conclusie 4, waarbij de stam lactose direct in D-tagatose om kan zetten.The preparation method of a recombinant strain of Escherichia coli (E. coli) according to claim 4, wherein the strain can directly convert lactose into D-tagatose. 6. Bereidingswerkwijze van een recombinante stam van Escherichia coli (E. coli) volgens conclusie 5, waarbij de optimale omstandigheden het volgende omvatten: temperatuur: 50 °C, pH: 8,0 en substraatlactoseconcentratie: 300 g/L.The preparation method of a recombinant strain of Escherichia coli (E. coli) according to claim 5, wherein the optimal conditions include: temperature: 50°C, pH: 8.0 and substrate lactose concentration: 300 g/L.
NL2030021A 2021-12-03 2021-12-03 L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR NL2030021B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL2030021A NL2030021B1 (en) 2021-12-03 2021-12-03 L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2030021A NL2030021B1 (en) 2021-12-03 2021-12-03 L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR

Publications (1)

Publication Number Publication Date
NL2030021B1 true NL2030021B1 (en) 2023-06-21

Family

ID=81927916

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2030021A NL2030021B1 (en) 2021-12-03 2021-12-03 L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR

Country Status (1)

Country Link
NL (1) NL2030021B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3543334A1 (en) * 2018-03-23 2019-09-25 Danmarks Tekniske Universitet A novel cell-based platform for converting lactose containing feedstocks into value-added compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3543334A1 (en) * 2018-03-23 2019-09-25 Danmarks Tekniske Universitet A novel cell-based platform for converting lactose containing feedstocks into value-added compounds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 9 April 2019 (2019-04-09), "Lactococcus lactis strain QL001 L-arabinose isomerase mRNA, complete cds.", XP002807687, retrieved from EBI accession no. EMBL:MH940215 Database accession no. MH940215 *
FARAHAT MOHAMED G: "CODON OPTIMIZATION AND CO-EXPRESSION OF THERMOSTABLE beta-GALACTOSIDASE AND L-ARABINOSE ISOMERASE IN LACTOCOCCUS LACTIS FOR SINGLE-STEP PRODUCTION OF FOOD-GRADE D-TAGATOSE", BIOCHEM. CELL. ARCH., vol. 20, no. 1, 1 April 2020 (2020-04-01), pages 2545 - 2552, XP055968836 *
HERMAN R E ET AL: "CLONING AND EXPRESSION OF THE BETA-D GALACTOSIDASE GENE FROM STREPTOCOCCUS-THERMOPHILUS IN ESCHERICHIA-COLI", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 52, no. 1, 1 July 1986 (1986-07-01), pages 45 - 50, XP002283748, ISSN: 0099-2240 *
ZHANG GUOYAN ET AL: "Exploring a Highly D-Galactose Specific L-Arabinose Isomerase From Bifidobacterium adolescentis for D-Tagatose Production", FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, vol. 8, 29 April 2020 (2020-04-29), XP055968834, DOI: 10.3389/fbioe.2020.00377 *

Similar Documents

Publication Publication Date Title
US20180023073A1 (en) Aldolase, aldolase mutant, and method and composition for producing tagatose by using same
TWI700370B (en) A composition for producing tagatose and methods for producing tagatose using the same
JP3557289B2 (en) Recombinant thermostable enzyme that releases trehalose from non-reducing carbohydrates
WO1992002614A1 (en) Novel thermostable pullulanases
TWI704227B (en) A composition for producing tagatose and methods for producing tagatose using the same
EP4276171A1 (en) Bacillus subtilis genetically engineered bacterium for producing tagatose and method for preparing tagatose
CN111394292B (en) Multi-way composite neuraminic acid-producing bacillus subtilis and application thereof
JP2022535648A (en) Use of thermostable β-glucosidase in the production of gentiooligosaccharides
CN113817763B (en) Directed evolution method, mutant and application of beta-galactosidase family genes
CN113637660A (en) Beta-galactosidase GalNC3-89 and preparation method and application thereof
JP3810457B2 (en) Recombinant thermostable enzyme that converts maltose to trehalose
JP3557288B2 (en) Recombinant thermostable enzyme that produces non-reducing carbohydrates with terminal trehalose structure from reducing starch sugars
CN111394410B (en) High-catalytic-activity neuraminic acid synthase and application thereof
CN111411066B (en) Double-way composite neuraminic acid-producing bacillus subtilis and construction method thereof
CN105969713B (en) Genetic engineering bacterium for high yield of maltooligosyl trehalose hydrolase and application thereof
CN109988778B (en) Sucrose phosphorylase gene and application thereof
NL2030021B1 (en) L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR
CN111455003A (en) Method for preparing D-psicose from microalgae
JP3650632B2 (en) Recombinant enzyme that converts maltose to trehalose
CN113736762B (en) alpha-L-rhamnosidase mutant and application thereof in preparation of pullulan
CN113005132B (en) D-psicose-3-epimerase gene and application method thereof
CN114317565B (en) Starch branching enzyme from myxobacteria, gene thereof, engineering bacteria containing gene and application of engineering bacteria
CN106119235B (en) A kind of DPE and its application from bulkholderia cepasea
CN105087520B (en) A method of promoting recombinant extremely heat-resistant alpha-amylase solubility expression
KR0133727B1 (en) Polypeptide possessing isoamylase activity andpre paration method thereof